[1] |
Kleinman CS, Nehgme RA. Cardiac arrhythmias in the human fetus [J]. Pediatr Cardiol, 2004, 25(3): 234-251.
|
[2] |
Lopriore E, Aziz MI, Nagel HT, et al. Long-term neurodevelopmental outcome after fetal arrhythmia [J]. Am J Obstet Gynecol, 2009, 2001(1): 46.e1-46.e5.
|
[3] |
Simpson J. Fetal arrhythmias∥Allan L, Hornberger LK, Sharland G (eds). Textbook of Fetal Cardiology[M]. London: Green-wich Medical Media, 2000: 423-437.
|
[4] |
夏家辉,李麓云,王璐. 染色体病[M]. 北京:科学出版社,1989: 228.
|
[5] |
Yagel S, Cohen SM, Aehiron R. Examination of the fetal heart by five short-axis views: a proposed screening method for comprehensive cardiac evaluation [J]. Ultrasound Obstet Gynecol, 2001, 17(5): 367-369.
|
[6] |
Wacker-Gussmann A, Strasburger JF, Cuneo BF, et al. Diagnosis and treatment of fetal arrhythmia [J]. Am J Perinatol, 2014, 31(7): 617-628.
|
[7] |
田志云,Huhta JC. 胎儿超声心动图手册[M]. 上海:同济大学出版社,1994: 52-62.
|
[8] |
Reed KL. Fetal arrhythmias: etiology, dignosis, pathophysiology, and treatment [J]. Semin Perinatol, 1989, 13(4): 294-304.
|
[9] |
Porat S, Anteby EY, Hamani Y, et al. Fetal supraventricular tachycardia diagnosed and treated at 13 weeks of gestation: a case report [J]. Ultrasound Obstet Gynecol, 2003, 21(3): 302-305.
|
[10] |
王鸿,耿丹明. 胎儿阵发性室上性心动过速的超声诊断及治疗 [J/CD]. 中华医学超声杂志:电子版,2009, 6(4): 718-724.
|
[11] |
Shand AW, Dickinson JE, D'Orsogna L. Refractory fetal supraventricular tachycardia and obstetric cholestasis [J]. Fetal Diagn Ther, 2008, 24(3): 277-281.
|
[12] |
Kohl T, Tercanli S, Kececioglu D, et al. Direct fetal administration of adenosine for the termination of incessant supraventricular tachycardia [J]. Obstet Gynecol, 1995, 85(5 Pt 2): 873-874.
|
[13] |
Kerenyi TD, Gleicher N, Meller J, et al. Transplacental cardioversion of intrauterine supraventricular tachycardia with digitalis [J]. Lancet, 1980, 2(8191): 393-394.
|
[14] |
Zhou K, Zhou R, Zhu Q, et al. Evaluation of therapeutic effect and cytokine change during transplacental digoxin treatment for fetal heart failure associated with fetal tachycardia, a case-control study [J]. Int J Cardiol, 2013, 169(4): e62-e64.
|
[15] |
Husain A, Hubail Z, Al Banna R. Fetal supraventricular tachycardia, treating the baby by targeting the mother [J]. BMJ Case Rep, 2013, 2013.pii: bcr2012008515.
|
[16] |
Boldt T, Eronen M, Andersson S. Long-term outcome in fetuses with cardiac arrhythmias [J]. Obstet Gynecol, 2003, 102(6): 1372-1379.
|
[17] |
Cuneo BF. Treatment of fetal tachycardia [J]. Heart Rhythm, 2008, 5(8): 1216-1218.
|
[18] |
van der Heijden LB, Oudijk MA, Manten GT, et al. Sotalol as first-line treatment for fetal tachycardia and neonatal follow-up [J]. Ultrasound Obstet Gynecol, 2013, 42(3): 285-293.
|
[19] |
Jaeggi ET, Carvalho JS, De Groot E, et al. Comparison of transplacental treatment of fetal supraventricular tachyarrhythmias with digoxin, flecainide, and sotalol: results of a nonrandomized multicenter study [J]. Circulation, 2011, 124(16): 1747-1754.
|
[20] |
Shah A, Moon-Grady A, Bhogal N, et al. Effectiveness of sotalol as first-line therapy for fetal supraventricular tachyarrhythmias [J]. Am J Cardiol, 2012, 109(11): 1614-1618.
|
[21] |
Vigneswaran TV, Callaghan N, Andrews RE, et al. Correlation of maternal flecainide concentrations and therapeutic effect in fetal supraventricular tachycardia [J]. Heart Rhythm, 2014, 11(11): 2047-2053.
|
[22] |
Flores Pérez J, Ramírez Mendiola B, Flores Pérez C, et al. Preparation and evaluation of unitary doses of propafenone used in children with supraventricular tachycardia: a pilot study [J]. Eur Rev Med Pharmacol Sci, 2013, 17(2): 189-194.
|
[23] |
Uzun O, Babaoglu K, Sinha A, et al. Rapid control of foetal supraventricular tachycardia with digoxin and flecainide combination treatment [J]. Cardiol Young, 2012, 22(4): 372-380.
|